Abstract
Ranolazine (R) is approved for the management of chronic angina. While the exact mechanism of action of R is unknown, it has been found to affect the cardiac late sodium current, as well as inhibit the rapid delayed rectifier potassium current, which is effective in patients with ventricular and
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
